14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $21.75 $29.07 Wednesday, 24th Apr 2024 ARWR stock ended at $23.29. This is 2.06% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 3.71% from a day low at $22.89 to a day high of $23.74.
90 days $21.75 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
Feb 17, 2021 $86.71 $87.82 $84.59 $86.70 850 871
Feb 16, 2021 $89.03 $89.36 $85.37 $87.40 565 831
Feb 12, 2021 $88.46 $89.91 $86.70 $88.20 489 166
Feb 11, 2021 $88.95 $90.42 $86.66 $88.34 609 073
Feb 10, 2021 $90.00 $92.60 $87.01 $87.48 940 760
Feb 09, 2021 $88.41 $91.10 $87.66 $89.80 549 820
Feb 08, 2021 $89.64 $90.47 $86.12 $88.41 1 156 316
Feb 05, 2021 $82.50 $91.70 $78.55 $90.47 1 459 657
Feb 04, 2021 $81.61 $84.89 $79.77 $83.92 915 654
Feb 03, 2021 $79.92 $81.89 $79.45 $80.33 568 201
Feb 02, 2021 $80.78 $82.00 $79.95 $80.52 713 377
Feb 01, 2021 $78.03 $80.40 $77.28 $79.76 543 462
Jan 29, 2021 $78.39 $80.89 $76.31 $77.17 978 039
Jan 28, 2021 $78.16 $79.29 $76.50 $77.75 711 781
Jan 27, 2021 $79.55 $81.93 $75.03 $76.82 1 001 078
Jan 26, 2021 $84.29 $85.88 $80.86 $81.14 655 390
Jan 25, 2021 $81.85 $84.67 $80.29 $84.13 696 485
Jan 22, 2021 $79.81 $82.24 $79.50 $82.07 820 276
Jan 21, 2021 $83.58 $84.12 $79.49 $80.02 558 845
Jan 20, 2021 $82.59 $84.98 $82.40 $83.44 656 129
Jan 19, 2021 $80.61 $83.45 $80.61 $82.15 538 566
Jan 15, 2021 $81.90 $84.35 $80.52 $80.74 650 556
Jan 14, 2021 $80.95 $84.12 $80.40 $82.86 480 067
Jan 13, 2021 $82.11 $84.55 $80.89 $81.00 709 162
Jan 12, 2021 $80.42 $82.93 $80.01 $82.69 550 420
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT